New CEO for Jubilant Biosys
Jubilant Biosys Limited has appointed Giuliano Perfetti as CEO. Company executives say Perfetti has more than 20 years of experience across diverse businesses and global markets with expertise in strategy, sales, marketing, and business development. He has led business transformation and expansion programs working in reputed names including Accenture and Astrazeneca among others.
“I am thrilled to be joining the Jubilant Bhartia Group at such a pivotal time of growth and investment bringing a fully integrated offering from drug discovery to development and commercial production,” Perfetti says.
Prior to joining Jubilant Biosys, Perfetti was associated with Fabbrica Italiana Sintetici (F.I.S) as chief commercial officer and was responsible for strategizing and executing the company’s growth plan and ramping up the global scale-up and commercial service business.
“Jubilant Biosys is delighted to have Giuliano come on board as we make rapid progress in expanding our drug discovery services and CDMO business through investments in infrastructure and new capacity,” says Shyam S Bhartia, chairman, and Hari S Bhartia, co-chairman and managing director, Jubilant Pharmova.